BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7235674)

  • 1. Differences among Providencia species in their in vitro susceptibilities to five antibiotics.
    Penner JL; Preston MA
    Antimicrob Agents Chemother; 1980 Dec; 18(6):868-71. PubMed ID: 7235674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species differences in susceptibilities of Proteeae spp. to six cephalosporins and three aminoglycosides.
    Penner JL; Preston MA; Hennessy JN; Barton LJ; Goodbody MM
    Antimicrob Agents Chemother; 1982 Aug; 22(2):218-21. PubMed ID: 6765415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antimicrobial susceptibilities of clinical isolates of Morganella-proteus-providencia group of bacteria].
    Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y
    Jpn J Antibiot; 1991 Feb; 44(2):140-9. PubMed ID: 2041155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural antibiotic susceptibility of Providencia stuartii, P. rettgeri, P. alcalifaciens and P. rustigianii strains.
    Stock I; Wiedemann B
    J Med Microbiol; 1998 Jul; 47(7):629-42. PubMed ID: 9839568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species.
    Ducan IB; Penner JL
    Can Med Assoc J; 1975 Jul; 113(1):29-31. PubMed ID: 807310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Providencia rustigianii: a new species in the family Enterobacteriaceae formerly known as Providencia alcalifaciens biogroup 3.
    Hickman-Brenner FW; Farmer JJ; Steigerwalt AG; Brenner DJ
    J Clin Microbiol; 1983 Jun; 17(6):1057-60. PubMed ID: 6874899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activity of semisynthetic penicillins against Proteeae.
    Hawkey PM; Pedler SJ; Turner A
    Antimicrob Agents Chemother; 1983 Apr; 23(4):619-21. PubMed ID: 6859841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antimicrobial susceptibility patterns of the Proteeae in Japan, 1989].
    Igari J; Hayashi Y; Shitara S; Shitara M; Yoshimoto K; Ohmizu Y; Umetsu M; Sasaki J; Kawana R; Yoshida T
    Jpn J Antibiot; 1993 Apr; 46(4):285-94. PubMed ID: 8515560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy between cephalosporin and aminoglycoside antibiotics against Providencia and Proteus.
    Hyams PJ; Simberkoff MS; Rahal JJ
    Antimicrob Agents Chemother; 1974 Jun; 5(6):571-7. PubMed ID: 15825407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in-vitro activity of quinolone carboxylic acids against Proteeae.
    Hawkey PM; Hawkey CA
    J Antimicrob Chemother; 1984 Nov; 14(5):485-9. PubMed ID: 6511707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Speciation, serotyping, antimicrobial sensitivity and plasmid content of Proteeae from the environment of calf-rearing units in South West England.
    Hawkey PM; Penner JL; Linton AH; Hawkey CA; Crisp LJ; Hinton M
    J Hyg (Lond); 1986 Dec; 97(3):405-17. PubMed ID: 3540110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C; Kauffman CA
    Infection; 1978; 6(3):111-5. PubMed ID: 98451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nosocomial multiply resistant Providencia stuartii: a long-term outbreak with multiple biotypes and serotypes at one hospital.
    Kocka FE; Srinivasan S; Mowjood M; Kantor HS
    J Clin Microbiol; 1980 Feb; 11(2):167-9. PubMed ID: 7358840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual Enterobacteriaceae. "Proteus rettgeri" that "change" into Providencia stuartii.
    Farmer JJ; Hickman FW; Brenner DJ; Schreiber M; Rickenbach DG
    J Clin Microbiol; 1977 Oct; 6(4):373-8. PubMed ID: 334793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of trehalose fermentation and L-glutamic acid decarboxylation for identification of biochemically aberrant Providencia stuartii strains.
    Fischer R; Penner JL; Zurinaga G; Riddle C; Sämisch W; Brenner DJ
    J Clin Microbiol; 1989 Sep; 27(9):1969-72. PubMed ID: 2570791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
    Meyer RD
    J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of selected beta-lactam and aminoglycoside antibiotics against cephalothin-resistant Enterobacteriaceae.
    Lewis RP; Meyer RD; Kraus LL
    Antimicrob Agents Chemother; 1976 May; 9(5):780-6. PubMed ID: 949175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic resistance in Providencia stuartii isolated in hospitals.
    McHale PJ; Keane CT; Dougan G
    J Clin Microbiol; 1981 Jun; 13(6):1099-104. PubMed ID: 7251830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of antibiogram, antibiotic resistance genes and class 1 and 2 integrons in tribe Proteeae with IMP27 gene for the first time in Providencia sp. isolated from pet turtles.
    Pathirana HNKS; Shin GW; Wimalasena SHMP; Hossain S; De Silva BCJ; Dahanayake PS; Heo GJ
    Lett Appl Microbiol; 2018 Dec; 67(6):620-627. PubMed ID: 30238643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro comparison of synergism between cefamandole and gentamicin or tobramycin by the triple layer agar method with enzymatic inactivation.
    Yourassowsky E; Schoutens E; Van der Linden MP; Lismont MJ
    Infection; 1979; 7(5):237-9. PubMed ID: 389805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.